During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

The Jefferson County Senior Services Division is hosting The MMRF Multiple Myeloma Community Connect event on Thursday, Nov.

Although myeloma is treatable, it is generally not curable, and advanced therapies like blood stem cell transplantation can ...

Are an adult with relapsed or refractory multiple myeloma Have tried at least four ... and CT scans, or perform bone marrow biopsies to take samples for examination. Do not stop your Tecvayli ...

Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

Dearbhla was diagnosed in July 2022 with multiple myeloma, a type of bone marrow cancer that can affect the spine, skull, ...

This may happen if tumors in the bone marrow spread to the ... According to the American Cancer Society, the 5-year relative survival rates for multiple myeloma are: 79% for localized multiple ...

Myeloma is a type of cancer that affects plasma, a type of blood cell that bone marrow produces. The cancer causes an overproduction of plasma cells, which causes tumors to develop. Myeloma cells ...